ALFA Filings
Every announcement, straight from the exchange
Every Lords Mark Industries business update announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Lord’s Mark Industries received MHRA registration for its IVD portfolio, enabling UK commercial sales from December 2026. The milestone supports its international healthcare expansion strategy.
Promoter Sachidanand Hariram Upadhyay proposed reinvesting proceeds from his prior sale of shares into the company's medical device unit expansion.
Lord’s Mark Industries has advanced its AI-powered breast cancer screening technology to final clinical trial stages. The company targets a global commercial launch by April 2027.
Lord's Mark Industries Limited received a manufacturing license for its Biomescan Analytics Platform. This platform is India's first licensed In Vitro Diagnostic Software for microbiome assessments.